Abstract:Background The APOE4 gene is a strong risk factor for Alzheimer’s disease (AD). However, an understanding of the APOE4 genotype‐associated cellular and molecular processes in the brains remains unclear. Method To clarify the APOE4‐related pathogenic pathways in AD, we performed single‐nuclei RNA‐sequencing and spatial enhanced resolution omics sequencing on the brains of aging human APOE3‐knockin mice and APOE4 knock‐in mice. We also investigated the relationship between different cell types and AD‐related pathology in APOE knock‐in mice using immunostaining. We conducted amplification‐based single molecule in situ hybridization to validate the characteristics of the APOE4‐specific subcluster. To substantiate the APOE knock‐in mice analyses, we also re‐analyzed a published single‐nuclei RNA‐seq dataset containing postmortem prefrontal cortex tissue samples from patients with AD and controls. Result We identified seven distinct cell types in brains from APOE‐knockin mice, and observed oligodendrocytes with most unique differentially expressed genes (Figure 1). And we found significantly increased Alzheimer’s disease‐related pathologies (including intracellular beta‐amyloid and phosphorylated tau) in oligodendrocytes in the hippocampus of APOE4‐KI mice compared to APOE3‐KI mice. Furthermore, an APOE4‐specific oligodendrocyte subcluster was identified. This subcluster had a dysregulated autophagy flux signature, which may affect neuronal oxidative stress and synaptic function (Figure 2). Both excitatory and inhibitory neurons presented dysregulation of genes related to synapse plasticity. Additionally, the oligodendrocyte subcluster significantly correlated with neuronal loss, beta‐amyloid deposition and tau phosphorylation in the brain tissues examined. We also found a similar oligodendrocyte subcluster in post‐mortem brains from AD patients. Conclusion Altogether, this study suggests the specific oligodendrocyte subcluster is related to the susceptibility of APOE4 to AD, and targeting autophagy changes in oligodendrocyte may be a novel therapeutic intervention approach in APOE4 carriers.

Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits

Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia

The APOE-R136S mutation protects against APOE4-driven Tau pathology, neurodegeneration and neuroinflammation

Neuronal apolipoprotein E4 increases cell death and phosphorylated tau release in alzheimer disease

Neuronal ApoE4 in Alzheimer's disease and potential therapeutic targets

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGF-mediated checkpoints

APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFβ-mediated checkpoints

Neuronal APOE4-induced Early Hippocampal Network Hyperexcitability in Alzheimer's Disease Pathogenesis

Neuronal APOE4-induced Early Hippocampal Network Hyperexcitability in Alzheimers Disease Pathogenesis

Cell-autonomous Effects of APOE4 in Restricting Microglial Response in Brain Homeostasis and Alzheimer’s Disease

Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer’s disease pathology in a mouse model

Cell type-specific roles of APOE4 in Alzheimer disease

Cell-autonomous effects of APOE4 in restricting microglial response in brain homeostasis and Alzheimer's disease

ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease

Single‐nuclei Spatiotemporal Transcriptomics Reveal an APOE4‐associated Specific Oligodendrocyte Signature

Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy

APOE ε4 associates with microglial activation independently of Aβ plaques and tau tangles

APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer’s disease patient iPSC-derived cerebral organoids

APOE4 Impairs Microglia ‐ Astrocyte Crosstalk in Alzheimer Disease

APOE4 accelerates advanced-stage vascular and neurodegenerative disorder in old Alzheimer’s mice via cyclophilin A independently of amyloid-β